Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Johnson & Johnson

Johnson & Johnson (JNJ) Stock Overview

Explore Johnson & Johnson’s financial performance, market position, analyst ratings, and future outlook.

JNJ●NYSE
HealthcareDrug Manufacturers - General
$267.37
$6.04(2.21%)
U.S. Market opens in 1h 25m

Johnson & Johnson (JNJ)

Meyka AI Score

Z

Key Financials

Market Cap645.3B
P/E Ratio31.13
EPS (TTM)$10.73
ROE0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$265.81
3 Months$291.59
1 Year Target$201.94

JNJ Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Johnson & Johnson (NYSE: JNJ) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Johnson & Johnson's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of JNJ on the NYSE shows an RSI of 60.39, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $201.94 for the NYSE listing.

Key metrics behind Johnson & Johnson's NYSE-traded stock include a P/E ratio of 31.13 and a market capitalization of 645.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of JNJ on the NYSE.

Price Performance (NYSE: JNJ)

1-Day Change
-2.06%
5-Day Change
2.73%
1-Month Change
7.62%
3-Month Change
16.77%
6-Month Change
10.43%
Year-to-Date (YTD) Change
29.39%
1-Year Change
49.73%
3-Year Change
60.006%
5-Year Change
49.23%
All-Time (Max) Change
21848.36%

Contact Information

https://www.jnj.com
732 524 0400
One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Company Facts

1,417,000 Employees
IPO DateJan 2, 1962
CountryUS
Actively Trading

Frequently Asked Questions